GO
Loading...

Enter multiple symbols separated by commas

NuVasive Inc

  • Correction: Earns-NuVasive story Tuesday, 5 May 2015 | 1:08 PM ET

    SAN DIEGO— In a story May 4 about NuVasive's first-quarter earnings, The Associated Press reported erroneously that the company expects revenue for the year of $180 million. NuVasive posts 1 Q profit, results beat Wall Street forecasts. SAN DIEGO— NuVasive Inc. on Monday reported first-quarter net income of $31.6 million, after reporting a loss in the same...

  • NuVasive tops Street 1Q forecasts Monday, 4 May 2015 | 5:54 PM ET

    SAN DIEGO _ NuVasive Inc. on Monday reported first-quarter net income of $31.6 million, after reporting a loss in the same period a year earlier. NuVasive expects full-year earnings to be $1.10 per share, with revenue expected to be $180 million. NuVasive shares have fallen 3 percent since the beginning of the year.

  • April 1- NuVasive Inc's founder and chief executive of 16 years, Alex Lukianov, resigned after an independent investigation showed he had not complied with the medical device maker's expense reimbursement and personnel policies. NuVasive did not disclose the exact nature of the violations and a spokeswoman declined to comment beyond the company statement.

  • April 1- NuVasive Inc said its chief executive of 16 years had resigned after an independent investigation showed he had not complied with the medical device maker's expense reimbursement and personnel policies. The amounts involved appeared immaterial to financial results, Jack Blair, NuVasive's lead independent director, said in a statement.

  • April 1- NuVasive Inc said Chief Executive Office Alex Lukianov resigned after an independent investigation showed he had not complied with the medical device maker's expense reimbursement and personnel policies. The company said the amounts involved were not material to financial results. NuVasive also appointed board member Greg Lucier as interim CEO.

  • NuVasive rises as 3Q revenue tops estimates Wednesday, 24 Oct 2012 | 4:10 PM ET

    SAN DIEGO-- Medical device maker NuVasive Inc. said Wednesday that it turned a profit in the third quarter, and its shares bounced back as its earnings topped estimates. NuVasive said its revenue grew 12 percent to $148.4 million. NuVasive reported net income of $2.4 million, or 5 cents per share.

  • Sector Snap: Orthopedic device makers Thursday, 11 Oct 2012 | 3:54 PM ET

    NEW YORK-- Shares of orthopedic implant makers mostly traded higher Thursday, but analysts said industry bellwether Biomet's earnings are cause for concern.

  • U.S. stocks were poised to rise at the open, with the S&P 500 set to hit its highest since 2007, as a surprise drop in the jobless rate gives legs to this week's rally. S&P 500 futures rose 6.2 points and were above fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract.

  • **ZYNGA INC, Thursday close $2.81, down 22.4 pct premarket. Brokerages lowered their price targets on Zynga's stock by up to $3 per share after the social-games maker slashed its 2012 outlook for the second time due to a decline in paying customers. Facebook, which derives over a tenth of its revenue from fees paid by Zynga, was also set to open lower as was Groupon.

  • MARKET PULSE- Zynga, Facebook Friday, 5 Oct 2012 | 7:37 AM ET

    U.S. stock index futures pointed to a mixed open on Wall Street, with futures for the S&P 500 slipping by 0.1 percent, while the Dow Jones and Nasdaq 100 futures contracts rose around 0.1 percent. **ZYNGA INC, Thursday close $2.81, down 19.2 pct premarket.

  • Sprint, Bebe Stores, NuVasive are market movers Thursday, 4 Oct 2012 | 5:29 PM ET

    NEW YORK-- Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and Nasdaq Stock Market:. Thor Industries Inc., up $1.39 at $36.95. Bloomberg reported that the wireless company might consider a counterbid to T-Mobile USA's proposed acquisition of MetroPCS.

  • NuVasive tumbles on weak 3Q revenue estimate Thursday, 4 Oct 2012 | 2:13 PM ET

    NEW YORK-- Shares of NuVasive Inc. lost about a third of their value Thursday after the spinal device maker said its third-quarter revenue will come up short of its previous estimates. THE SPARK: After the market closed Wednesday, NuVasive said it expects about $147 million in revenue in the third quarter.

  • The S&P 500 rose for a fourth session after a report suggested improvement in the labor market ahead of Friday's closely watched monthly payrolls report. The Nasdaq Composite Index gained 6.10 points, or 0.19 percent, to 3,141.40. **COLLABRX INC, $6.80, up 79.4 pct.

  • U.S. stocks rose for a fourth session on Thursday following encouraging comments by European Central Bank President Mario Draghi on tools to tackle the region's debt crisis and in support of the euro. **COLLABRX INC, $6.9, up 83.3 pct.

  • U.S. stocks rose at the open after labor market data came in within expectations and following encouraging comments by European Central Bank President Mario Draghi on tools to tackle the region's debt crisis. **NUVASIVE INC, $14.9, down 34 pct.

  • U.S. stock index futures added to gains after European Central Bank President Mario Draghi said growth risks are on the downside and should be contained by effective policymaker action. Brokerages Canaccord Genuity, Robert W. Baird& Co, Mizuho Securities USA, BMO Capital Markets and ThinkEquity Llc cut their price targets on the stock.

  • U.S. stock index futures added to gains after European Central Bank President Mario Draghi said growth risks are on the downside and should be contained by effective policymaker action. **NUVASIVE INC, Wednesday close $22.62, down 29.3 pct premarket. **INFORMATICA CORP, Wednesday close $33.63, down 19.7 pct premarket.

  • Stocks to Watch: FB, MAR, UPS, COST & More Thursday, 4 Oct 2012 | 8:25 AM ET
    market-insider-stocks-to-watch-200.jpg

    Take a look at some of Thursday morning's early movers:

  • RESEARCH ALERT-ThinkEquity cuts NuVasive target price Thursday, 4 Oct 2012 | 7:39 AM ET

    *ThinkEquity cuts NuVasive Inc target price to $27 from $30; rating. Reuters Station users, click. 1568. Reuters Station users, click. 4899.

  • U.S. stock index futures pointed to a higher open on Wall Street on Thursday, with futures for the S&P 500, the Dow Jones and the Nasdaq 100 rising between 0.2 and 0.5 percent. **NUVASIVE INC, Wednesday close $22.62, down 27.4 pct premarket.